Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin

Lisa L. Morselli, Arlet Nedeltcheva, Rachel Leproult, Karine Spiegel, Enio Martino, Jean Jacques Legros, Roy E. Weiss, Jean Mockel, Eve Van Cauter, Georges Copinschi

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Objectives: We previously reported that adult patients with GH deficiency (GHD) due to a confirmed or likely pituitary defect, compared with healthy controls individually matched for age, gender, and BMI, have more slow-wave sleep (SWS) and higher delta activity (a marker of SWS intensity). Here, we examined the impact of recombinant human GH (rhGH) therapy, compared with placebo, on objective sleep quality in a subset of patients from the same cohort. Design: Single-blind, randomized, crossover design study. Methods: Fourteen patients with untreated GHD of confirmed or likely pituitary origin, aged 22-74 years, participated in the study. Patients with associated hormonal deficiencies were on appropriate replacement therapy. Polygraphic sleep recordings, with bedtimes individually tailored to habitual sleep times, were performed after 4 months on rhGH or placebo. Results: Valid data were obtained in 13 patients. At the end of the rhGH treatment period, patients had a shorter sleep period time than at the end of the placebo period (479±11 vs 431±19 min respectively; P=0.005), primarily due to an earlier wake-up time, and a decrease in the intensity of SWS (delta activity) (559±125 vs 794G219 mV2 respectively; P=0.048). Conclusions: Four months of rhGH replacement therapy partly reversed sleep disturbances previously observed in untreated patients. The decrease in delta activity associated with rhGH treatment adds further evidence to the hypothesis that the excess of high-intensity SWS observed in untreated pituitary GHD patients is likely to result from overactivity of the hypothalamic GHRH system due to the lack of negative feedback inhibition by GH.

Original languageEnglish (US)
Pages (from-to)763-770
Number of pages8
JournalEuropean Journal of Endocrinology
Volume168
Issue number5
DOIs
StatePublished - May 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin'. Together they form a unique fingerprint.

  • Cite this

    Morselli, L. L., Nedeltcheva, A., Leproult, R., Spiegel, K., Martino, E., Legros, J. J., Weiss, R. E., Mockel, J., Van Cauter, E., & Copinschi, G. (2013). Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin. European Journal of Endocrinology, 168(5), 763-770. https://doi.org/10.1530/EJE-12-1037